TCF7L2 Variant rs116052600: Understanding Sleep Apnea Associations
The genetic variant rs116052600 is a common single nucleotide polymorphism located near the TCF7L2 gene. Research has identified this locus as being associated with susceptibility to obstructive sleep apnea and variations in nocturnal oxyhemoglobin saturation profiles.
What each genotype means
Typical nocturnal oxygenation profile
You carry two copies of the C allele at this locus near the TCF7L2 gene. Published genome-wide association studies link this baseline genotype with typical nocturnal oxygen levels and average baseline susceptibility to obstructive sleep apnea. Because obstructive sleep apnea is a complex trait heavily influenced by anatomy, age, and weight, genetic findings alone do not predict sleep outcomes.
Found in approximately 45% to 50% of individuals of European descent, and more frequent in several non-European ancestries.
Mildly altered nocturnal oxygenation
You carry one copy of the T allele near TCF7L2, which has shown limited statistical association with obstructive sleep apnea susceptibility and mild alterations in nighttime oxyhemoglobin saturation. However, the evidence supporting this relationship is modest and not universally replicated across all diverse ancestries. This statistical association is not diagnostic of sleep apnea and represents only a minor contribution compared to anatomical and lifestyle factors.
Carried by approximately 40% to 45% of people of European ancestry.
Altered nocturnal oxygenation tendency
You carry two copies of the T allele near TCF7L2. In preliminary genetic association literature, this genotype is correlated with a modest predisposition toward obstructive sleep apnea symptoms and reduced nocturnal oxyhemoglobin saturation measures. The clinical evidence base remains limited, and this genetic pattern does not establish a diagnosis of sleep apnea or replace a clinical sleep evaluation.
Observed in roughly 8% to 10% of individuals in European populations, with differing frequencies in other global ancestries.
What is rs116052600?
A single nucleotide polymorphism, or SNP, is a variation at a single position in a DNA sequence among individuals. The variant rs116052600 is a specific location in the human genome situated near the TCF7L2 gene. In genomics, researchers study these variants to understand how subtle differences in our genetic code might influence complex traits or health conditions. Because this SNP is located in a non-coding region near a gene known for its role in metabolic regulation, scientists investigate whether it acts as a regulatory element that influences how nearby genes are expressed. It is important to note that the presence of a specific allele at this site does not determine a health outcome on its own; rather, it is one of many factors—including environment, lifestyle, and other genetic markers—that contribute to an individual's biological profile.
The Role of the TCF7L2 Gene
The TCF7L2 gene, which stands for Transcription Factor 7-Like 2, is widely recognized in scientific literature for its significant role in glucose metabolism and insulin secretion. It is perhaps best known as one of the most potent genetic loci associated with the risk of type 2 diabetes. The protein encoded by this gene is a key component of the Wnt signaling pathway, which is essential for cell development and homeostasis. While its primary fame comes from metabolic research, the gene's influence is broad. Because TCF7L2 is expressed in various tissues, researchers have explored its potential involvement in other physiological processes, including those that might indirectly affect sleep quality or respiratory control during rest. Understanding this gene provides a foundation for why variants in its vicinity, such as rs116052600, are of interest to researchers studying complex, multi-factorial conditions.
Research and Evidence Strength
The association between rs116052600 and obstructive sleep apnea (OSA) is categorized as having limited evidence. Obstructive sleep apnea is a complex condition characterized by repeated pauses in breathing during sleep, often influenced by a combination of anatomical, environmental, and genetic factors. While genome-wide association studies (GWAS) have flagged this locus as being linked to OSA susceptibility and altered nocturnal oxyhemoglobin saturation—a measure of how well oxygen is maintained in the blood during sleep—these findings are considered preliminary. The genetic architecture of sleep apnea is highly heterogeneous, meaning that many different genes likely contribute small effects. Consequently, while the statistical signal at this locus is notable, it does not currently serve as a diagnostic tool. Further research is required to confirm the functional mechanisms by which this variant might influence sleep-related physiological traits across diverse populations.
Population Frequency
Genetic variants are distributed differently across the globe, and rs116052600 is considered a common variant. In non-Finnish European populations, the minor allele frequency is approximately 0.31. This means that a significant portion of the population carries at least one copy of the variant allele. Because frequency can vary significantly between ancestral groups, researchers often look at these differences to understand the evolutionary history of a variant and its potential impact. Studies assessing genetic affinity have shown that while many super-populations share similar genetic structures, there can be distinct stratification within sub-populations. Understanding these frequencies helps scientists contextualize the prevalence of associated traits, though it is important to remember that frequency alone does not dictate the clinical relevance of a variant for any specific individual.
Interpreting Your Genetic Information
If you encounter information about your genotype at rs116052600, it is essential to view it through the lens of scientific uncertainty. Because the evidence linking this variant to sleep apnea is limited, it cannot be used to predict whether an individual will develop the condition. Genetic testing for such variants is generally for educational or research purposes and should not be used to make medical decisions. If you have concerns about your sleep quality, such as snoring, daytime fatigue, or observed breathing pauses, the most effective step is to consult a healthcare professional. They can provide a clinical evaluation, which is the only reliable way to assess sleep health. Never use genetic data to self-diagnose or alter your health management plan without the guidance of a qualified clinician who can interpret your results in the context of your overall health history.
How common is this variant?
The variant is common, with a minor allele frequency of approximately 0.31 in non-Finnish European populations.
Frequently asked questions
Does having the rs116052600 variant mean I have sleep apnea?
No. This variant is only associated with a statistical susceptibility to sleep apnea in research studies. It is not a diagnostic test, and many people with this variant do not have sleep apnea.
Can I use this information to prevent sleep apnea?
There is no evidence that knowing your genotype for this variant can be used to prevent sleep apnea. Lifestyle factors like maintaining a healthy weight and regular exercise are generally more impactful for sleep health.
Is this variant related to diabetes?
The TCF7L2 gene is strongly associated with type 2 diabetes, but rs116052600 is specifically noted in the context of sleep apnea research. Always consult a doctor for concerns regarding diabetes risk.
Where can I get a clinical test for this variant?
Clinical testing for this specific SNP is not standard medical practice because it does not provide actionable diagnostic information. If you are concerned about sleep apnea, see a sleep specialist for a clinical sleep study.
Sources & further reading
Educational information only, last refreshed 10/18/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs116052600?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TCF7L2
This variant in the TCF7L2 gene is one of the strongest genetic risk factors for the development of type 2 diabetes across multiple ethnic groups.
Variant in TCF7L2 consistently associated with altered pancreatic beta-cell function and predisposition to type 2 diabetes.
Resides within the TCF7L2 genomic locus, which is strongly linked to altered glucose regulation and type 2 diabetes susceptibility.
This variant is a well-established marker within the TCF7L2 locus, which is recognized as the most potent genetic risk factor for type 2 diabetes across multiple ethnic groups.
Variant in TCF7L2 strongly associated with type 2 diabetes risk and modulation of glycemic response to dietary fiber.
Intronic variant in TCF7L2 strongly associated with increased risk of Type 2 Diabetes through impaired insulin secretion.